Talphera (TLPH) FCF Margin Growth (5y) (2016 - 2025)
Powered by 
Analysis
Talphera (TLPH) FCF Margin Growth (5y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -25.04 Mn |
| Mar 31, 2025 | -911,170.00 |
| Dec 31, 2023 | 10,135.00 |
| Sep 30, 2023 | -80,922.00 |
| Jun 30, 2023 | -130,240.00 |
| Mar 31, 2023 | 114,263.00 |
| Mar 31, 2022 | -178,180.00 |
| Dec 31, 2021 | -40.14 Mn |
| Sep 30, 2021 | -3,786.00 |
| Jun 30, 2021 | -205,892.00 |
| Mar 31, 2021 | -169,230.00 |
| Dec 31, 2020 | -146,335.00 |
| Sep 30, 2020 | -56,061.00 |
| Jun 30, 2020 | 24,050.00 |
| Mar 31, 2020 | 248,360.00 |
| Dec 31, 2019 | 124,781.00 |
| Sep 30, 2019 | -194,850.00 |
| Jun 30, 2019 | 1.35 Mn |
| Mar 31, 2019 | 662,389.00 |
| Dec 31, 2018 | -159,191.00 |